Joseph LaPlume serves as the Corporate Executive Vice President of Corporate Development and Strategy at Charles River Laboratories International, a leading global provider of essential products and services to the pharmaceutical, biotechnology, and medical device industries. In his current role, LaPlume is responsible for driving the company's strategic growth initiatives, overseeing mergers and acquisitions, and fostering partnerships that enhance Charles River's capabilities and market position. His leadership has been instrumental in guiding the company through a period of significant expansion and innovation. Prior to joining Charles River Laboratories, LaPlume held several senior executive positions in the life sciences industry. He has a proven track record of successfully leading corporate development efforts, having spearheaded numerous acquisitions and strategic alliances that have strengthened the companies he has served. LaPlume's extensive experience in the sector, combined with his strategic vision, has enabled him to make significant contributions to Charles River's growth and success. His ability to identify and capitalize on emerging opportunities has been a key factor in the company's ability to stay at the forefront of the industry. Under LaPlume's guidance, Charles River Laboratories has continued to expand its service offerings and global reach, solidifying its position as a trusted partner to its clients. His strategic insights and leadership have been crucial in navigating the complex landscape of the life sciences industry, ensuring that the company remains agile and responsive to the evolving needs of its customers. LaPlume's dedication to driving innovation and growth has made him an invaluable asset to Charles River Laboratories and the broader life sciences community.